Comparative Study
Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors
- PMID: 203383
Item in Clipboard
Comparative Study
Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors
Cancer Res.
1978 Mar.
No abstract available
Similar articles
-
Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.Cancer Res. 1978 Jun;38(6):1730-3. Cancer Res. 1978. PMID: 274175
-
Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.Cancer Res. 1990 Jul 15;50(14):4401-6. Cancer Res. 1990. PMID: 2364392
-
Transport and metabolism of deoxycytidine and 1-beta-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis.Cancer Res. 1978 Apr;38(4):978-89. Cancer Res. 1978. PMID: 205355 No abstract available.
-
Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.Cancer Res. 1979 Aug;39(8):3129-33. Cancer Res. 1979. PMID: 455296 No abstract available.
-
The role of cholesterol in malignancy.Prog Exp Tumor Res. 1978;22:275-316. doi: 10.1159/000401203. Prog Exp Tumor Res. 1978. PMID: 209495 Review. No abstract available.
Cited by
-
Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.Proc Natl Acad Sci U S A. 1981 Aug;78(8):5132-6. doi: 10.1073/pnas.78.8.5132. Proc Natl Acad Sci U S A. 1981. PMID: 6975478 Free PMC article.
-
Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidine.Eur J Nucl Med. 1986;12(3):137-40. doi: 10.1007/BF00276706. Eur J Nucl Med. 1986. PMID: 2428619
-
Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.Cancer Chemother Pharmacol. 1987;19(1):69-74. doi: 10.1007/BF00296260. Cancer Chemother Pharmacol. 1987. PMID: 3815728
-
A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and -resistant leukemic cells.Cancer Chemother Pharmacol. 1990;27(2):151-6. doi: 10.1007/BF00689101. Cancer Chemother Pharmacol. 1990. PMID: 2249332
-
Selective uptake and retention of anticancer agents by sensitive cells.Cancer Chemother Pharmacol. 1980;4(4):221-5. doi: 10.1007/BF00255265. Cancer Chemother Pharmacol. 1980. PMID: 6449312 Review.